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Routine 6-month an-
giographic follow-up was 
common practice back in 
the 90’s due to relatively 
high rates of significant 
restenosis. Back then, 
the rate of repeated tar-
get vessel revasculariza-
tion (TVR) could be as high as 30–40% in specific 
patient subsets, such as diabetics, long lesions 
or small vessels [1]. Invasive imaging is also 
a necessary part of the comprehensive evaluation 
of new devices and coronary intervention strate-
gies, which have clearly helped the scientific com-
munity to bring down target vessel failure rates to 
one-digit figures. However, the systematic perfor-
mance of repeated catheterization in asymptomatic, 
ischemia-free patients, undoubtedly leads to more 
interventions, the so called “oculostenotic reflex”, 
without clear reduction in myocardial infarction 
or cardiovascular mortality [2, 3]. But, is this also 
true for patients with left main or last remaining 
vessel percutaneous coronary intervention (PCI)? 
In this issue of “Cardiology Journal”, Au-
rigemma et al. [4] present interesting results from 
a retrospective study evaluating the impact of 
routine angiographic follow-up after successful PCI 
of unprotected left main stenoses. Approximately 
90% of the 190 patients were treated with a 1-stent 
technique and index procedures were performed 
with intravascular imaging in roughly 1 out of 4 cas-
es. Despite intervention-
alists’ recommendations 
to perform routine 6- to 
9-month catheterizations 
in all patients, it was not 
done in 48% of those 
eligible cases due, most 
likely, to patient and phy-
sician preference. 
As expected, study 
groups had some impor-
tant differences at baseline: patients in the clinical 
follow-up group tended to be older (although not 
a statistically significant difference), with also 
a trend to a higher rate of renal failure and with 
more prior myocardial infarctions. Patients in the 
angiographic follow-up group were more commonly 
treated with a 2-stent technique, although rates 
of final kissing-balloon were rather similar (65%). 
The main finding of this study is that routine angio-
graphic group had 3× higher TVR rates, but more 
importantly cardiac mortality were significantly 
lower at a mean follow-up of 35 months.
Different groups have tried to analyze the 
impact of systematic angiographic follow-up after 
sucessful left main PCI [5–7]. In contrast to the 
study of Aurigemma et al. [4], other Italian investi-
gators, looking into a similar retrospective database 
of 198 patients with left-main treated between 2002 
and 2007, found that routine angiographic follow-
up did not reduce myocardial infarction or cardiac 
death [5]. In a larger multicenter registry enrolling 
1267 patients with left main treated with second-
generation drug-eluting stent (DES), 440 patients 
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were selected by propensity score matching taking 
into consideration clinical and procedural varia-
bles and compared planned angiographic follow 
up with clinical only follow up [6]. After a median 
follow up of 16 months, the rates of all cause and 
cardiovascular death were significantly lower in the 
angiographic group (6% vs. 14%, p = 0.01 and 3% 
vs. 6%, p = 0.04). The rates of TVR were higher 
(15% vs. 5%, p < 0.001), although this is clearly 
a worthy price to pay if it leads to reduced mortality. 
Routine angiography was not mandated in 
the SYNTAX and EXCEL trials. These 2 studies 
have shown that left main PCI was equivalent to 
coronary artery bypass grafting (CABG) in Syn-
tax scores less than 32 [7, 8]. Recently published 
ReACT study from Japan, a randomized clinical 
trial of 700 patients, has shown an inconclusive 
difference in outcomes at 5 years between routine 
angiography and clinical follow up in the left main 
subgroup due to small simple size [9].
Retrospective studies have important limita-
tions that should be considered before embracing 
the conclusion that one should re-catheterize all 
asymptomatic and ischemia-free patients with 
left main PCI. Most important, there are relevant 
baseline differences between study groups, not al-
ways corrected by multivariate analyses. Probably, 
clinicians felt more relutanct to send asymptomatic 
elderly patients, with renal failure and poorer left 
ventricular function for routine catheterization. 
These patients are much more prone to present 
severe complications, not always avoidable by 
treating restenosis, such as heart failure, sepsis, 
or arrhythmic sudden death. Second, we have no 
data on how this “clinical only” follow up was done. 
It could have been only simple office consultations 
with no intention to look for non-invasive signs of 
ischemia or left ventricular dysfunction. In that 
case, physicians could have missed an opportunity 
to perform a control angiography and prevent some 
of the events that might have ultimately lead to a 
worse prognosis. What would be the difference be-
tween the two groups if systematic imaging stress 
tests (or maybe also cardiac computed tomography) 
were performed 4–6 months after index revascu-
larization in “clinical-only” patients? 
Another practical issue is the timing of an-
giographic follow up. The rationale for re-cath-
eterization after a 6-month interval is based on 
typical patterns of restenosis after bare-metal 
stent implantation [1]. However, although a 6 or 
9 month interval seems adequate in many cases 
of side-branch or focal in-stent restenosis, other 
cases of late “catch-up” phenomenon or neoath-
erosclerosis occur > 1–2 years after first and 
second generation DES and would be missed in 
this control angiography [10]. In addition, late or 
very-late stent thrombosis are better avoided by 
optimal stent deployment, in most cases based on 
intravascular imaging during the index procedure, 
and probably can not be prevented by performing 
routine 6–9 months angiographic follow up.
So, what are the main implications of this study 
to clinical practice? Current guidelines have been 
recently issued and grant a IIb recommendation 
to control angiography in asymptomatic patients 
with high-risk PCI, including unprotected left 
main [11]. The American College of Cardiology 
Foundation/American Heart Association/Society 
for Cardiovascular Angiography and Interven-
tions (ACCF/AHA/SCAI) guidelines removed 
a previously class IIA recommendation of routine 
angiography in 2011 PCI guidelines [12]. Now 
that better stents are available and experience in 
treating left main lesions with PCI has been gained, 
optimal long-term results must be persued, at least 
equivalent to those achieved with arterial grafts. 
Thus, randomized studies are needed to defini-
tively solve animportant question of what is the 
best follow-up strategy in this previously CABG- 
-exclusive disease. Until then, patients should at 
least be provided with an optimal medical treat-
ment, a close follow-up including a low threshold 
to repeat catheterization, non-invasive imaging 
including a stress test, and perhaps routine angi-
ography in some high-risk cases. 
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